Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

goldman-sachs-maintains-buy-on-adt-(adt-inc.)-march-2026

Goldman Sachs Maintains Buy on ADT (ADT Inc.) March 2026

Mar 3, 2026

Goldman Sachs maintained a Buy on ADT (ADT Inc.) on March 02, 2026 after flagging possible negative investor…

Read more
cowen-maintains-hold-on-purecycle-technologies,-inc.-(pct)-march-2026

Cowen Maintains Hold on PureCycle Technologies, Inc. (PCT) March 2026

Mar 3, 2026

On March 2, 2026, Cowen & Co. maintained a Hold on PureCycle Technologies, Inc. (PCT) and lowered its…

Read more
overweight-maintained-for-dyne-therapeutics-(dyn)-by-morgan-stanley-march-2026

Overweight Maintained for Dyne Therapeutics (DYN) by Morgan Stanley March 2026

Mar 3, 2026

Morgan Stanley maintained Overweight on Dyne Therapeutics, Inc. (DYN) on March 02, 2026. This DYN analyst rating came…

Read more
morgan-stanley-maintains-overweight-on-netease,-inc.-(ntes)-mar-2026

Morgan Stanley Maintains Overweight on NetEase, Inc. (NTES) Mar 2026

Mar 3, 2026

Morgan Stanley maintained an Overweight rating on NetEase, Inc. (NTES) on March 02, 2026, signaling continued conviction in…

Read more
evercore-isi-maintains-outperform-on-apple-inc.-(aapl)-march-02,-2026

Evercore ISI Maintains Outperform on Apple Inc. (AAPL) March 02, 2026

Mar 2, 2026

Evercore ISI on March 02, 2026 at 11:30 AM maintained an Outperform rating on Apple Inc. (AAPL), a…

Read more
ubs-maintains-buy-on-sionna-therapeutics,-inc.-(sion)-march-02,-2026

UBS Maintains Buy on Sionna Therapeutics, Inc. (SION) March 02, 2026

Mar 2, 2026

Get analyst ratings, AI forecasts, and market updates in your inbox every morning. 12% average open rate and…

Read more
rbc-capital-downgrades-uniqure-nv.-(qure)-to-sector-perform-mar-2026

RBC Capital Downgrades uniQure N.V. (QURE) to Sector Perform Mar 2026

Mar 2, 2026

RBC Capital downgraded uniQure N.V. (QURE) from Outperform to Sector Perform on March 02, 2026. The move is…

Read more
oppenheimer-maintains-outperform-on-urogen-pharma-ltd.-(urgn)-march-2026

Oppenheimer Maintains Outperform on UroGen Pharma Ltd. (URGN) March 2026

Mar 2, 2026

Oppenheimer maintained an Outperform rating on UroGen Pharma Ltd. (URGN) on March 02, 2026, a clear signal in…

Read more
credo-technology-earnings-are-imminent;-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-c

Credo Technology Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings C

Mar 2, 2026

Credo Technology Group Holding Ltd (NASDAQ:CRDO) will release earnings results for its third quarter, after the closing bell…

Read more
this-nexttrip-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-monday

This NextTrip Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Mar 2, 2026

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
needham-maintains-buy-on-teleflex-(tfx),-pt-raised-to-$147-feb-26-2026

Needham Maintains Buy on Teleflex (TFX), PT Raised to $147 Feb 26 2026

Mar 2, 2026

Needham maintained a Buy rating on Teleflex (TFX) and raised its price target to $147 on Feb 26,…

Read more
wolfe-maintains-outperform-on-roche-holding-ag-(rhhby)-feb-26,-2026

Wolfe Maintains Outperform on Roche Holding AG (RHHBY) Feb 26, 2026

Mar 2, 2026

On Feb 26, 2026 Wolfe Research maintained an Outperform on Roche Holding AG, the key fact driving today’s…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 40
  6. 41
  7. 42
  8. 43
  9. 44
  10. 45
  11. 46
  12. ...
  13. 396
  14. »

Posts pagination

Newer posts Page 1 … Page 43 … Page 396 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.